The PROGRESS trial three years later: Clear and accurate interpretations of studies are needed
- PMID: 15591580
- PMCID: PMC535467
- DOI: 10.1136/bmj.329.7479.1404
The PROGRESS trial three years later: Clear and accurate interpretations of studies are needed
Figures
Comment on
- 
  
  The PROGRESS trial three years later: time for a balanced report of effectiveness.BMJ. 2004 Oct 23;329(7472):968-70. doi: 10.1136/bmj.329.7472.968. BMJ. 2004. PMID: 15499116 Free PMC article.
References
- 
    - PROGRESS Collaborative Group. Randomised trial of perinopril-based blood pressure lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358: 1033-41. - PubMed
 
- 
    - Hackam DG, Kapral MK. Progress in clinical neurosciences: pharmacotherapies for the secondary prevention of stroke. Can J Neurol Sci 2004;3: 295-303. - PubMed
 
- 
    - Fox KM for the European Trial on Reduction of Cardiac Events with Perindopril in Stable Coronary Artery Disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003:362: 782-8. - PubMed
 
Publication types
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
- Medical
 
         
              